Clinical Trial Update: A Prospective, Multicenter, Open-label, Safety and Preliminary Efficacy Study of the Surgical Implantation of OPKO's Glaucoma Drainage Device (AquashuntTM) in Patients With Refractory Chronic Forms of Open Angle Glaucoma (OAG) [NA]

View source ↗

Summary

A prospective, multicenter open-label study evaluated the safety and preliminary efficacy of surgically implanting OPKO's Aquashunt glaucoma drainage device in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Open-angle Glaucoma

Drugs mentioned

• Aquashunt Glaucoma Drainage Device

Snippet

Sponsor: OPKO Health, Inc. | Conditions: Glaucoma | NA | Status: COMPLETED